general-pediatrics-congress-2018-scientifictracks

5 / 11

Page 21
Note:
D e c e m b e r 1 2 - 1 3 , 2 0 1 8 | A b u D h a b i , U A E
Journal of RNA and Genomics| Volume 14 General Pediatrics Congress 2018 Current Pediatric Research | ISSN: 0971-9032 | Volume 22
GENERAL PEDIATRICS, ADOLESCENT
MEDICINE AND NEONATOLOGY CONGRESS
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
Bahauddin Ibraheem Sallout, Curr Pediatr Res 2018, Volume 22 | DOI: 10.4066/0971-9032-C3-008
CAN MCA DOPPLER PREDICT MORTALITY
IN FOETUSES WITH CONGENITAL
HYDROCEPHALUS
Bahauddin Ibraheem Sallout
Women’s Specialized Hospital, Saudi Arabia
The objective of this study is to investigate the impact of abnormal middle
cerebral artery (MCA) Doppler on the perinatal mortality in fetuses with
congenital hydrocephalus (CH).
Methods: A prospective study of all fetuses with CH who delivered at our
hospital over a period of 7 years. Data were obtained from the ultrasound,
Labor room and intensive neonatal care unit (NICU) database. The Perinatal
mortality rates were evaluated in relation to the following measures, associat-
ed congenital anomalies, cortical mantle thickness (CMT), and MCA Doppler
abnormalities (absent or reversed diastole). The main outcome measure was
perinatal mortality rate in relation to MCA Doppler changes.
Results: A total of 85 cases of CH were diagnosed and managed. The birth
prevalence of CH was 2.44 per 1000 live births. On one hand, the perinatal
mortality rate was higher in those fetuses with non-isolated hydrocephalus,
(37.25% (19/51) versus (35.29% (12/34, p¼0.854 and in those cases with
CMT <10 mm, 38.78% (19/49) versus 33.33% (12/36) in those with CMT >10
mm, p¼0.607. On the other hand, the perinatal mortality rate was significantly
higher in those fetuses with abnormal MCA Doppler, (100% (13/13) versus
25% (18/72), OR¼78.0, 95% CI (5.52–44085124.60), p<0.001.
Conclusions: Abnormal fetal MCA Doppler (absent or reversed diastole) ap-
pears to be a poor prognostic indicator with significantly high perinatal mor-
tality in fetuses with CH.
Bahauddin Ibraheem Sallout is a certified with Mater-
nal-Fetal Medicine (MFM) consultant from university of
Ottawa, Canada, with American Specialty in Ultrasound
in Obstetrics and Gynecology. He have special training
in fetal echocardiograph and 3D/4D sonography. He
developed the ultrasound unit and established the MFM
department, and currently, the medical director for the
Women’s Specialized Hospital, King Fahad Medical City,
Riyadh, Saudi Arabia. He has 15 publications in the field
of obstetrics ultrasound and fetal medicine, and he par-
ticipated and presented in many international and local
conferences.
BIOGRAPHY